API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. F /
  3. DMN.F

Diamyd Medical AB (publ) (DMN F) stock market data APIs

€1.052 0(0%) as of November 4, 2024
Price chart is built with Anychart

Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes in adults (LADA); and Remygen, an immunomodulation therapy, that is in phase I/II clinical trial for the treatment of with type 1 diabetes, type 2 diabetes, and LADA. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in type 1 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was founded in 1984 and is headquartered in Stockholm, Sweden.

Diamyd Medical AB (publ) Financial Data Overview

1.052
1.052
-
1.052
1.052
0.55-1.784
118 M
101 M
130 K
2.096
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'DMN',
Type: 'Common Stock',
Name: 'Diamyd Medical AB (publ)',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'SE0005162880',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'August',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Diamyd Medical AB (publ) Fundamental Data is available in our Financial Data APIs

  • Net Revenue 130 K
  • EBITDA -141 694 000
  • Earnings Per Share -0.13
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Diamyd Medical AB (publ) Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Diamyd Medical AB (publ) End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Diamyd Medical AB (publ) latest news via APIs

Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes

STOCKHOLM, Dec. 16, 2020 /PRNewswire/ -- Diamyd Medical and the Critical Path Institute (C-Path) are proud to announce their collaboration to significantly improve the scientific community's insight i...
  • CRITICAL PATH INSTITUTE
  • DIABETES
  • DIABETES UK
  • DIABETES VACCINE
  • DIAMYD MEDICAL
  • JDRF
  • PHARMACEUTICAL INDUSTRY
  • TYPE 1 DIABETES
  • TYPE 2 DIABETES

Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes

STOCKHOLM, Dec. 16, 2020 /PRNewswire/ -- Diamyd Medical and the Critical Path Institute (C-Path) are proud to announce their collaboration to significantly improve the scientific community's insight i...
  • CRITICAL PATH INSTITUTE
  • DIABETES
  • DIABETES UK
  • DIABETES VACCINE
  • DIAMYD MEDICAL
  • JDRF
  • PHARMACEUTICAL INDUSTRY
  • TYPE 1 DIABETES
  • TYPE 2 DIABETES
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com